NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • Health Economics
        • Ethics in the NIHR Oxford BRC
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient and Public Involvement
    • For patients and the public
    • For researchers
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
You are here: Home > News > News for Oxford Blood Group

Oxford Blood Group - Exchange Newsletters and related news

See Oxford Blood Group

Spin-out company Alethiomics launched

17 December 2021 · Listed under Gene and Cell Therapy, Oxford Blood Group

Image link to post

A new Oxford-based drug-discovery company has been launched with the aim of developing targeted therapies for a specific family of blood cancers. Alethiomics was founded by Oxford BRC-supported researchers Professor Adam Mead  and Professor Beth Psaila, with support from Oxford ... READ MORE

New atlas reveals pre-birth development of blood cells in bone marrow

29 September 2021 · Listed under Gene and Cell Therapy, Inflammation across Tissues, Oxford Blood Group

A new study has provided the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow. The study, published in Nature, is part of the Human Cell Atlas (HCA) initiative to provide comprehensive reference maps of every cell type in the human ... READ MORE

Researchers develop algorithm to diagnose deep vein thrombosis

15 September 2021 · Listed under Digital Health from Hospital to Home, Gene and Cell Therapy, Oxford Blood Group

Image link to post

Researchers are developing an artificial intelligence (AI) algorithm to diagnose deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs ... READ MORE

Study investigates responses to COVID-19 treatment in chronic lymphoid leukaemia patients

27 August 2021 · Listed under COVID-19, Gene and Cell Therapy, Oxford Blood Group

The COVID-19 pandemic has led to understandable anxiety within the blood cancer community about how their illness may affect their ability to overcome COVID-19 infection. Members of the Oxford Centre for Haematology have led a collaborative research project looking at the response of patients ... READ MORE

Oxford researchers meet patients to discuss new Advanced Cellular Therapies Centre

29 January 2021 · Listed under Gene and Cell Therapy, Oxford Blood Group

Oxford researchers have met with members of the Oxford Blood Group to discuss plans for an Advanced Cellular Therapies Centre. Plans for the creation of an Oxford Advanced Cellular Therapies Centre have been supported by NIHR Research Capability Funding. The proposed centre will bring together ... READ MORE

Oxford Blood Group: Exchange Newsletter Issue 3 vol 1 / June 2019

9 July 2019 · Listed under Oxford Blood Group

Image link to post

... READ MORE

Patient involvement partnership sets priorities for rare inherited anaemias

28 February 2019 · Listed under Gene and Cell Therapy, Oxford Blood Group, Partnerships for Health, Wealth and Innovation, Patient and Public Involvement and Engagement

Image link to post

On the occasion of Rare Diseases Day, marked every year on the last day of February, we are sharing this article about how patients, carers, clinicians and researchers are collaborating to decide key questions to shape future research into rare forms of anaemia. Patients with anaemia lack red ... READ MORE

Oxford Blood Group: Exchange Newsletter Issue 1 vol 2 / Nov 2018

26 November 2018 · Listed under Oxford Blood Group

Image link to post

... READ MORE

For Patients and the Public

  • Welcome
  • Training for patient and public contributors
  • Public events
Register for the involvement email bulletin
Follow @OxfordPPI

More Information

  • Opportunities for patient and public involvement
  • Meet the team
  • Patient and public groups
    • Patient and Public Advisory Group
    • Diversity in Research Group
    • Other patient and public groups
  • Case Studies
  • Strategy
  • Videos
  • News
  • Guidance for researchers
Follow @OxfordPPI

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre